FLOVENT DISKUS 50 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Flovent Diskus 50, and what generic alternatives are available?
Flovent Diskus 50 is a drug marketed by Glaxo Grp Ltd and is included in one NDA.
The generic ingredient in FLOVENT DISKUS 50 is fluticasone propionate. There are twenty-nine drug master file entries for this compound. Seventy-eight suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flovent Diskus 50
A generic version of FLOVENT DISKUS 50 was approved as fluticasone propionate by FOUGERA PHARMS on May 14th, 2004.
Summary for FLOVENT DISKUS 50
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 86 |
Clinical Trials: | 19 |
Patent Applications: | 4,474 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FLOVENT DISKUS 50 at DailyMed |
Recent Clinical Trials for FLOVENT DISKUS 50
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Becro Ltd. | Phase 1 |
Respirent Pharmaceuticals Co Ltd. | Phase 1 |
Becro Ltd. | Phase 3 |
Pharmacology for FLOVENT DISKUS 50
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for FLOVENT DISKUS 50
US Patents and Regulatory Information for FLOVENT DISKUS 50
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxo Grp Ltd | FLOVENT DISKUS 50 | fluticasone propionate | POWDER;INHALATION | 020833-001 | Sep 29, 2000 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FLOVENT DISKUS 50
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxo Grp Ltd | FLOVENT DISKUS 50 | fluticasone propionate | POWDER;INHALATION | 020833-001 | Sep 29, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
Glaxo Grp Ltd | FLOVENT DISKUS 50 | fluticasone propionate | POWDER;INHALATION | 020833-001 | Sep 29, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
Glaxo Grp Ltd | FLOVENT DISKUS 50 | fluticasone propionate | POWDER;INHALATION | 020833-001 | Sep 29, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FLOVENT DISKUS 50
See the table below for patents covering FLOVENT DISKUS 50 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Netherlands | 8100707 | ⤷ Try a Trial | |
Hong Kong | 58385 | ANDROSTANE CARBOTHIOATES | ⤷ Try a Trial |
Spain | 509539 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for FLOVENT DISKUS 50
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1305329 | 08C0014 | France | ⤷ Try a Trial | PRODUCT NAME: FLUTICASONE FUROATE; REGISTRATION NO/DATE: EU/1/07/434/001 20080111 |
2506844 | 2018C/022 | Belgium | ⤷ Try a Trial | PRODUCT NAME: EEN FARMACEUTISCH COMBINATIEPRODUCT DAT EEN FARMACEUTISCH AANVAARDBAAR ZOUT VAN UMECLIDINIUM (BV. UMECLIDINIUMBROMIDE), VILANTEROL OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN (BV. VILANTEROLTRIFENATAAT) EN FLUTICASONEFUROAAT OMVAT; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117 |
2506844 | LUC00077 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: PRODUIT DE COMBINAISON PHARMACEUTIQUE COMPRENANT UN SEL PHARMACEUTIQUEMENT ACCEPTABLE D'UMECLIDINIUM (PAR EXEMPLE LE BROMURE D'UMECLIDINIUM), LE VILANTEROL OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE (PAR EXEMPLE LE TRIFENATATE DE VILANTEROL) ET LE FUROATE DE FLUTICASONE; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |